India Cancer Biomarkers Market Report by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics), Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, and Others), Application (Diagnostics, Prognostics, Risk Assessment, Drug, Discovery and Development, and Others), End User (Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Region 2024-2032

India Cancer Biomarkers Market Report by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics), Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, and Others), Application (Diagnostics, Prognostics, Risk Assessment, Drug, Discovery and Development, and Others), End User (Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A21671
Buy Now

Market Overview:

India cancer biomarkers market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.3 Billion by 2032, exhibiting a growth rate (CAGR) of 13.70% during 2024-2032. The rising regional incidence of cancer, which has driven the demand for effective and early diagnostic tools, is driving the market.

Report Attribute
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023 US$ 2.6 Billion
Market Forecast in 2032 US$ 8.3 Billion
Market Growth Rate (2024-2032) 13.70%


Cancer biomarkers are molecules or genetic alterations that indicate the presence of cancer or provide information about its characteristics. These biomarkers play a crucial role in cancer diagnosis, prognosis, and treatment monitoring. They can be proteins, DNA, RNA, or other substances produced by cancer cells or the body in response to cancer. Detecting and analyzing these biomarkers enable early cancer diagnosis, facilitating timely intervention and improving patient outcomes. Additionally, biomarkers aid in tailoring personalized treatment plans by identifying specific genetic mutations or molecular signatures associated with the cancer. As research advances, the identification and utilization of cancer biomarkers continue to evolve, offering promise for more effective and targeted cancer therapies. The ongoing exploration of biomarkers contributes to the development of precision medicine, enhancing our ability to understand, diagnose, and treat cancer at a molecular level.

India Cancer Biomarkers Market Trends:

The cancer biomarkers market in India is experiencing robust growth due to several key drivers. Firstly, advancements in genomics and proteomics technologies have significantly contributed to the identification and validation of novel cancer biomarkers. Consequently, these technological breakthroughs have enhanced the precision and efficiency of cancer diagnosis and prognosis. Additionally, the increasing prevalence of cancer has fueled the demand for more accurate and early detection methods, driving the adoption of biomarker-based diagnostic tools. Moreover, collaborations between academic institutions, research organizations, and pharmaceutical companies have facilitated the development of innovative biomarker assays and platforms. This collaborative approach fosters a dynamic ecosystem that accelerates biomarker discovery and validation processes. Furthermore, the rising awareness among healthcare professionals and patients about the benefits of biomarker-based diagnostics has played a pivotal role in expanding the market. Overall, the confluence of technological advancements, growing disease burden, collaborative initiatives, and heightened awareness collectively propel the cancer biomarkers market forward in India, establishing it as a critical component in the contemporary landscape of cancer diagnostics and personalized medicine.

India Cancer Biomarkers Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on profiling technology, biomolecule, cancer type, application, and end user.

Profiling Technology Insights:

India Cancer Biomarkers Market

  • Omic Technologies
  • Imaging Technologies
  • Immunoassays
  • Cytogenetics
     

The report has provided a detailed breakup and analysis of the market based on the profiling technology. This includes omic technologies, imaging technologies, immunoassays, and cytogenetics.

Biomolecule Insights:

  • Genetic Biomarkers
  • Protein Biomarkers
  • Glyco-Biomarkers
     

A detailed breakup and analysis of the market based on the biomolecule have also been provided in the report. This includes genetic biomarkers, protein biomarkers, and glyco-biomarkers.

Cancer Type Insights:

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Stomach Cancer
  • Others
     

The report has provided a detailed breakup and analysis of the market based on the cancer type. This includes breast cancer, lung cancer, colorectal cancer, prostate cancer, stomach cancer, and others.

Application Insights:

  • Diagnostics
  • Prognostics
  • Risk Assessment
  • Drug Discovery and Development
  • Others
     

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes diagnostics, prognostics, risk assessment, drug discovery and development, and others.

End User Insights:

  • Hospitals
  • Academic and Research Institutions
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories
  • Others
     

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, academic and research institutions, ambulatory surgical centers, diagnostic laboratories, and others.

Regional Insights:

India Cancer Biomarkers Market By Region

  • North India
  • West and Central India
  • South India
  • East and Northeast India
     

The report has also provided a comprehensive analysis of all the major regional markets, which include North India, West and Central India, South India, and East and Northeast India.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

India Cancer Biomarkers Market Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
  • Profiling Technology
  • Biomolecule
  • Cancer Type
  • Application
  • End User
  • Region 
Profiling Technologies Covered Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics
Biomolecules Covered Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers
Cancer Types Covered Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Others
Applications Covered Diagnostics, Prognostics, Risk Assessment, Drug, Discovery and Development, Others
End Users Covered Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, Others
Regions Covered North India, West and Central India, South India, East and Northeast India
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the India cancer biomarkers market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the India cancer biomarkers market?
  • What is the breakup of the India cancer biomarkers market on the basis of profiling technology?
  • What is the breakup of the India cancer biomarkers market on the basis of biomolecule?
  • What is the breakup of the India cancer biomarkers market on the basis of cancer type?
  • What is the breakup of the India cancer biomarkers market on the basis of application?
  • What is the breakup of the India cancer biomarkers market on the basis of end user?
  • What are the various stages in the value chain of the India cancer biomarkers market? 
  • What are the key driving factors and challenges in the India cancer biomarkers?
  • What is the structure of the India cancer biomarkers market and who are the key players?
  • What is the degree of competition in the India cancer biomarkers market?

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the India cancer biomarkers market from 2018-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the India cancer biomarkers market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the India cancer biomarkers industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
India Cancer Biomarkers Market Report by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics), Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, and Others), Application (Diagnostics, Prognostics, Risk Assessment, Drug, Discovery and Development, and Others), End User (Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More